Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection.

Literature DB >> 27908966

The Need for Prudence When Using ¹⁸F-FDG PET as a Reference Standard for Lymphoma Detection.

Hugo J A Adams¹, Thomas C Kwee.

Abstract

Entities: Disease

Mesh：

Substances：
Fluorodeoxyglucose F18

Year: 2016 PMID： 27908966 DOI： 10.2967/jnumed.116.187096

Source DB: PubMed Journal: J Nucl Med ISSN： 0161-5505 Impact factor: 10.057

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. [¹⁸F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [¹⁸F]FDG in human xenograft models.

Authors: Narinée Hovhannisyan; Fabien Fillesoye; Stéphane Guillouet; Méziane Ibazizene; Jérôme Toutain; Fabienne Gourand; Samuel Valable; Benoit Plancoulaine; Louisa Barré
Journal: Theranostics Date: 2018-08-10 Impact factor: 11.556

2. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.

Authors: Tzu-Hua Chen-Liang; Taida Martín-Santos; Andrés Jerez; Guillermo Rodríguez-García; Leonor Senent; Cristina Martínez-Millán; Begoña Muiña; Mayte Orero; Anabel Teruel; Alejandro Martín; Joaquín Gómez-Espuch; Kyra Kennedy; Carmen Benet; José María Raya; Marta Fernández-González; Fátima de la Cruz; Marta Guinot; Carolina Villegas; Isabel Ballester; Mónica Baile; María Moya; Javier López-Jiménez; Laura Frutos; José Luis Navarro; Jon Uña; Rosa Fernández-López; Carolina Igua; José Contreras; Raquel Sánchez-Vañó; María Del Puig Cozar; Pilar Tamayo; Jorge Mucientes; José Javier Sánchez-Blanco; Elena Pérez-Ceballos; Francisco José Ortuño
Journal: Cancer Med Date: 2017-09-27 Impact factor: 4.452

2 in total

The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection.

1. [18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models.

2. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.

The Need for Prudence When Using ¹⁸F-FDG PET as a Reference Standard for Lymphoma Detection.

1. [¹⁸F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [¹⁸F]FDG in human xenograft models.